|By Marketwired .||
|May 5, 2014 07:00 AM EDT||
MADISON HEIGHTS, MI--(Marketwired - May 05, 2014) - InfuSystem Holdings, Inc. (NYSE MKT: INFU) ("InfuSystem" or the "Company"), a leading national provider of infusion pumps and related services for the healthcare industry in the United States, today reported that net income in the first quarter was $0.6 million, equal to $0.03 per diluted share, compared to $0.1 million, or $0.00 per diluted share, in the prior year period. Gross profit for the three months ending March 31, 2014, was $12.1 million, a 16% increase compared to the same prior year period.
Revenues in the first quarter of 2014 were $17.2 million, up $2.5 million, or 17%, from $14.7 million in the first quarter of 2013. During the period, net revenues from rentals increased 10% while net revenues from product sales increased 90% over the same period in 2013. During the first quarter of 2014, an opportunistic product sale of a particular pump at a low gross margin, resulted in $0.9 million in additional revenue, without which revenues from product sales would have increased 19% and total revenues would have increased 11% over the prior year period. The remaining increase in revenues was primarily related to the addition of larger customers and increased penetration into existing customer accounts, both in sales and rentals.
"First quarter results reflect solid across-the-board performance," stated Eric K. Steen, Chief Executive Officer. "Organic growth of pump rentals and infusion product sales are generating the cash necessary to enable investments in new IT systems that are expected to further accelerate current business gains. At the same time, we continue to gain meaningful traction in the pain management area. This is in large part fueled by recent investments in sales and marketing efforts," he added.
Mr. Steen also commented on current Executive Chairman Ryan Morris, who will be assuming the role of Non-Executive Chairman following the Company's May 8 Annual Meeting of Stockholders. "Ryan was the inspiration and impetus for the transformational change that has taken place at InfuSystem since his successful activist-led team gained control a little more than two years ago. His efforts are reflected in today's far-stronger organization and significantly higher shareholder valuation. I look forward to his continuing contributions."
Selling, General and Administrative expenses ("SG&A") increased to $7.6 million from $7.4 million, up approximately 2%, when compared to the first quarter of 2013. During the period, $0.2 million in severance was paid as part of the Company's strategic efforts to reshape the management team. Furthermore, compared to the prior year, the Company increased its spending in information technology, product expansion and cash versus stock compensation while reducing other SG&A expenses.
Other expenses were consistent for the three months ended March 31, 2014 compared to the similar period in 2013; excluding the one-time cash receipt of $0.3 million related to a mutual insurance policy received in the prior year period.
"We are very pleased with these strong results to date," said Jonathan P. Foster, Chief Financial Officer. "They meaningfully support our efforts to reduce the overall cost of existing long-term debt. We anticipate announcing additional advances during the course of this year."
Gross profit for the three months ended March 31, 2014 was $12.1 million, an increase of 16%, compared to the same period in the prior year. It represented 70% of revenues in the current period compared to 71% in the prior year. Without the aforementioned opportunistic pump sale, gross profit for the current period would have been 74%.
During the first quarter of 2014, we reassessed the estimated useful life of certain property and equipment. As a result, the estimated useful life of our medical equipment was changed from five to seven years due to the determination that we were using these assets longer than originally anticipated. A major factor in this change was the servicing of such equipment by our Kansas facility, which was acquired in 2010. As a result, disposal of such equipment has decreased significantly since that acquisition.
The change in the estimated useful lives of our medical equipment was accounted for as a change in accounting estimate, on a prospective basis, effective January 1, 2014. The change in estimated useful lives resulted in $0.5 million in less depreciation expense for the quarter ended March 31, 2014 than otherwise would have been recorded. As a result, cost of revenues in the current period is $0.5 million less than the same prior year period.
Selling and marketing expenses were $2.7 million compared to $2.4 million for the three months ended March 31, 2013. The increase in selling and marketing expenses was mainly attributed to increased commissions based on higher revenue for the comparable periods.
During the three months ended March 31, 2014, general and administrative ("G&A") expenses were $4.9 million compared to $5.0 million for the same prior year period. This maintaining of previous G&A spending levels is due to an increase during the current period in severance costs of $0.2 million, information technology ("IT") costs of $0.1 million, product services of $0.1 million and cash versus stock compensation of $0.1 million offset by a decrease in other G&A expenses by $0.1 million. In the prior year period, the Company experienced certain expenses of $0.3 million associated with a CEO search, the final Severance Payment made to the former CEO, and a one-time payment to an exiting Board member. G&A expenses have decreased from 34% to 28% of revenues for the first quarter of 2014 compared to the same period in the prior year.
Adjusted EBITDA was $3.3 million for the first quarter of 2014 compared to $3.7 million in 2013, which included $0.3 million for a one-time cash receipt related to a mutual insurance policy. The Company utilizes Adjusted EBITDA as a means to measure its operating performance. A reconciliation from Adjusted EBITDA, a non-GAAP measure, to net income can be found in the appendix.
"We are very pleased with maintaining strong EBITDA while investing in IT and new product services," said Jonathan P. Foster, Chief Financial Officer. He continued, "Total debt in the period increased slightly due to our $1.3 million investment in medical equipment in service within the current period, which was needed to support our rental revenue growth."
Net cash used in operations for the three months ended March 31, 2014 was $0.6 million compared to cash generated of $1.6 million for the prior year period. The decrease in cash is primarily due to increases in accounts receivable in 2014. The cash flow effect from this change in accounts receivable is a decrease of $0.8 million more than the decrease in the same quarter last year. Additionally, operating cash flow decreased due to a significant decrease of $1.8 million in accounts payable and other current liabilities.
As of March 31, 2014, we had cash and cash equivalents of $0.5 million and $6.2 million of availability on the Credit Facility compared to $1.1 million and $5.9 million, respectively, at December 31, 2013.
The Company maintained 2014 Guidance of high single digit revenue growth.
The Company will conduct a conference call for investors on Monday, May 5, 2014 at 9:00 a.m. Eastern Daylight Time to discuss first quarter performance and results. Eric K. Steen, Chief Executive Officer, and Jonathan P. Foster, Chief Financial Officer, will discuss the Company's financial performance and answer questions from the financial community. To participate in this call, please dial in toll-free (800) 447-0521 and use the confirmation number 37157235.
This press release contains information prepared in conformity with GAAP as well as non-GAAP information. It is management's intent to provide non-GAAP financial information to enhance understanding of its consolidated financial information as prepared in accordance with GAAP. This non-GAAP information should be considered by the reader in addition to, but not instead of, the financial statements prepared in accordance with GAAP. Each non-GAAP financial measure and the corresponding GAAP financial measure are presented so as to not imply that more emphasis should be placed on the non-GAAP measure. The non-GAAP financial information presented may be determined or calculated differently by other companies. Additional information about non-GAAP financial measures and a reconciliation of those measures to the most directly comparable GAAP measures are included later in this release.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison Heights, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. The Company's stock is traded on the NYSE MKT under the symbol INFU.
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements can be identified by words such as: "anticipate," "continue," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will" and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company's current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company's control. Actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the Company's expectations regarding financial condition or results of operations in future periods; the Company's expectations regarding potential legislative and regulatory changes impacting, among other things, the level of reimbursement received from the Medicare and state Medicaid programs including CMS competitive bidding; the Company's expectations regarding the size and growth of the market for its products and services; the Company's ability to execute its business strategies to grow its business, including its ability to introduce new products and services; the Company's ability to hire and retain key employees; the Company's ability to remain in compliance with its credit facility; the Company's dependence on its Medicare Supplier Number; changes in third-party reimbursement processes and rates; availability of chemotherapy drugs used in the Company's infusion pump systems; physicians' acceptance of infusion pump therapy over alternative therapies; the Company's dependence on a limited number of third party payors; the Company's ability to maintain relationships with health care professionals and organizations; the adequacy of the Company's allowance for doubtful accounts; the Company's ability to comply with changing health care regulations; sequestration; natural disasters affecting the Company, its customers or its suppliers; industry competition; the Company's ability to implement information technology improvements and to respond to technological changes; dependence upon the Company's suppliers; and such other factors as discussed in Part I, Item 1A. Risk Factors of the Company's Annual Report on Form 10-K for the year ended December 31, 2013. Any forward-looking statement contained in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.
FINANCIAL TABLES FOLLOW
INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS March 31, December 31, (in thousands, except share data) 2014 2013 ------------ ------------ (Unaudited) ASSETS Current Assets: Cash and cash equivalents $ 496 $ 1,138 Accounts receivable, less allowance for doubtful accounts of $5,875 and $4,774 at March 31, 2014 and December 31, 2013, respectively 12,099 10,697 Inventory 1,398 1,234 Other current assets 714 518 Deferred income taxes 2,296 2,296 ------------ ------------ Total Current Assets 17,003 15,883 Medical equipment held for sale or rental 2,955 3,664 Medical equipment in rental service, net of accumulated depreciation 15,405 14,438 Property & equipment, net of accumulated depreciation 915 872 Deferred debt issuance costs, net 1,661 1,817 Intangible assets, net 24,075 24,182 Deferred income taxes 15,998 16,300 Other assets 238 217 ------------ ------------ Total Assets $ 78,250 $ 77,373 ============ ============ LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable $ 5,153 $ 4,736 Current portion of long-term debt 5,305 5,118 Other current liabilities 2,479 3,187 ------------ ------------ Total Current Liabilities 12,937 13,041 Long-term debt, net of current portion 21,864 21,609 ------------ ------------ Total Liabilities $ 34,801 $ 34,650 ------------ ------------ Stockholders' Equity Preferred stock, $.0001 par value: authorized 1,000,000 shares; none issued - - Common stock, $.0001 par value: authorized 200,000,000 shares; issued and outstanding 22,195,958 and 21,998,268, respectively, as of March 31, 2014 and 22,158,041 and 21,960,351, respectively, as of December 31, 2013 2 2 Additional paid-in capital 89,925 89,783 Retained deficit (46,478) (47,062) ------------ ------------ Total Stockholders' Equity 43,449 42,723 ------------ ------------ Total Liabilities and Stockholders' Equity $ 78,250 $ 77,373 ============ ============
INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended March 31, -------------------------- (in thousands, except share and per share data) 2014 2013 ------------ ------------ (Unaudited) Net revenues: Rentals $ 14,850 $ 13,445 Product sales 2,392 1,256 ------------ ------------ Net revenues 17,242 14,701 Cost of revenues: Cost of revenues - Product, service and supply costs 2,890 2,579 Cost of revenues - Pump depreciation and loss on disposal 2,276 1,699 ------------ ------------ Gross profit 12,076 10,423 ------------ ------------ Selling, general and administrative expenses: Provision for doubtful accounts 2,107 1,660 Amortization of intangibles 629 672 Selling and marketing 2,655 2,408 General and administrative 4,909 5,031 ------------ ------------ Total selling, general and administrative: 10,300 9,771 ------------ ------------ Operating income 1,776 652 Other income (expense): Interest expense (827) (874) Other income (17) 312 ------------ ------------ Total other expense (844) (562) ------------ ------------ Income before income taxes 932 90 Income tax expense (349) (39) ------------ ------------ Net income $ 583 $ 51 ============ ============ Net income per share: Basic $ 0.03 $ 0.00 Diluted $ 0.03 $ 0.00 Weighted average shares outstanding: Basic 21,972,739 21,802,515 Diluted 22,456,143 22,238,160
INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Three Months Ended March 31, -------------------------- (in thousands) 2014 2013 ------------ ------------ (Unaudited) NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES $ (636) $ 1,632 ------------ ------------ INVESTING ACTIVITIES Purchases of medical equipment and property (1,127) (1,777) Proceeds from sale of medical equipment and property 1,252 1,093 ------------ ------------ NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 125 (684) ------------ ------------ FINANCING ACTIVITIES Principal payments on term loans and capital lease obligations (14,394) (2,802) Cash proceeds from bank loans and revolving credit facility 14,263 - ------------ ------------ NET CASH USED IN FINANCING ACTIVITIES (131) (2,802) ------------ ------------ Net change in cash and cash equivalents (642) (1,854) Cash and cash equivalents, beginning of period 1,138 2,326 ------------ ------------ Cash and cash equivalents, end of period $ 496 $ 472 ============ ============
INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES GAAP RECONCILIATION (UNAUDITED) Three Months Ended March 31, ------------------- (in thousands) 2014 2013 --------- --------- Net income (loss) $ 583 $ 51 Adjustments: Interest Expense 827 874 Income Tax Benefit 349 39 Depreciation 798 1,302 Amortization 629 672 --------- --------- EBITDA $ 3,186 $ 2,938 Stock compensation 142 458 Transition costs - 272 --------- --------- EBITDA - Adjusted $ 3,328 $ 3,668 ========= =========
The Dilenschneider Group
You think you know what’s in your data. But do you? Most organizations are now aware of the business intelligence represented by their data. Data science stands to take this to a level you never thought of – literally. The techniques of data science, when used with the capabilities of Big Data technologies, can make connections you had not yet imagined, helping you discover new insights and ask new questions of your data. In his session at @ThingsExpo, Sarbjit Sarkaria, data science team lead ...
Jul. 30, 2016 05:00 PM EDT Reads: 1,294
To leverage Continuous Delivery, enterprises must consider impacts that span functional silos, as well as applications that touch older, slower moving components. Managing the many dependencies can cause slowdowns. See how to achieve continuous delivery in the enterprise.
Jul. 30, 2016 04:30 PM EDT Reads: 566
WebRTC is bringing significant change to the communications landscape that will bridge the worlds of web and telephony, making the Internet the new standard for communications. Cloud9 took the road less traveled and used WebRTC to create a downloadable enterprise-grade communications platform that is changing the communication dynamic in the financial sector. In his session at @ThingsExpo, Leo Papadopoulos, CTO of Cloud9, discussed the importance of WebRTC and how it enables companies to focus...
Jul. 30, 2016 04:30 PM EDT Reads: 1,117
"My role is working with customers, helping them go through this digital transformation. I spend a lot of time talking to banks, big industries, manufacturers working through how they are integrating and transforming their IT platforms and moving them forward," explained William Morrish, General Manager Product Sales at Interoute, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Jul. 30, 2016 04:30 PM EDT Reads: 2,269
Up until last year, enterprises that were looking into cloud services usually undertook a long-term pilot with one of the large cloud providers, running test and dev workloads in the cloud. With cloud’s transition to mainstream adoption in 2015, and with enterprises migrating more and more workloads into the cloud and in between public and private environments, the single-provider approach must be revisited. In his session at 18th Cloud Expo, Yoav Mor, multi-cloud solution evangelist at Cloudy...
Jul. 30, 2016 04:15 PM EDT Reads: 628
Aspose.Total for .NET is the most complete package of all file format APIs for .NET as offered by Aspose. It empowers developers to create, edit, render, print and convert between a wide range of popular document formats within any .NET, C#, ASP.NET and VB.NET applications. Aspose compiles all .NET APIs on a daily basis to ensure that it contains the most up to date versions of each of Aspose .NET APIs. If a new .NET API or a new version of existing APIs is released during the subscription peri...
Jul. 30, 2016 02:30 PM EDT Reads: 1,061
Security, data privacy, reliability, and regulatory compliance are critical factors when evaluating whether to move business applications from in-house, client-hosted environments to a cloud platform. Quality assurance plays a vital role in ensuring that the appropriate level of risk assessment, verification, and validation takes place to ensure business continuity during the migration to a new cloud platform.
Jul. 30, 2016 02:00 PM EDT Reads: 530
SYS-CON Events announced today that 910Telecom will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Housed in the classic Denver Gas & Electric Building, 910 15th St., 910Telecom is a carrier-neutral telecom hotel located in the heart of Denver. Adjacent to CenturyLink, AT&T, and Denver Main, 910Telecom offers connectivity to all major carriers, Internet service providers, Internet backbones and ...
Jul. 30, 2016 01:30 PM EDT Reads: 973
Ovum, a leading technology analyst firm, has published an in-depth report, Ovum Decision Matrix: Selecting a DevOps Release Management Solution, 2016–17. The report focuses on the automation aspects of DevOps, Release Management and compares solutions from the leading vendors.
Jul. 30, 2016 01:00 PM EDT Reads: 1,856
Continuous testing helps bridge the gap between developing quickly and maintaining high quality products. But to implement continuous testing, CTOs must take a strategic approach to building a testing infrastructure and toolset that empowers their team to move fast. Download our guide to laying the groundwork for a scalable continuous testing strategy.
Jul. 30, 2016 01:00 PM EDT Reads: 2,124
Adding public cloud resources to an existing application can be a daunting process. The tools that you currently use to manage the software and hardware outside the cloud aren’t always the best tools to efficiently grow into the cloud. All of the major configuration management tools have cloud orchestration plugins that can be leveraged, but there are also cloud-native tools that can dramatically improve the efficiency of managing your application lifecycle. In his session at 18th Cloud Expo, ...
Jul. 30, 2016 12:00 PM EDT Reads: 1,364
SYS-CON Events announced today that LeaseWeb USA, a cloud Infrastructure-as-a-Service (IaaS) provider, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. LeaseWeb is one of the world's largest hosting brands. The company helps customers define, develop and deploy IT infrastructure tailored to their exact business needs, by combining various kinds cloud solutions.
Jul. 30, 2016 11:30 AM EDT Reads: 1,405
StackIQ has announced the release of Stacki 3.2. Stacki is an easy-to-use Linux server provisioning tool. Stacki 3.2 delivers new capabilities that simplify the automation and integration of site-specific requirements. StackIQ is the commercial entity behind this open source bare metal provisioning tool. Since the release of Stacki in June of 2015, the Stacki core team has been focused on making the Community Edition meet the needs of members of the community, adding features and value, while ...
Jul. 30, 2016 11:00 AM EDT Reads: 630
Qosmos has announced new milestones in the detection of encrypted traffic and in protocol signature coverage. Qosmos latest software can accurately classify traffic encrypted with SSL/TLS (e.g., Google, Facebook, WhatsApp), P2P traffic (e.g., BitTorrent, MuTorrent, Vuze), and Skype, while preserving the privacy of communication content. These new classification techniques mean that traffic optimization, policy enforcement, and user experience are largely unaffected by encryption. In respect wit...
Jul. 30, 2016 11:00 AM EDT Reads: 552
For basic one-to-one voice or video calling solutions, WebRTC has proven to be a very powerful technology. Although WebRTC’s core functionality is to provide secure, real-time p2p media streaming, leveraging native platform features and server-side components brings up new communication capabilities for web and native mobile applications, allowing for advanced multi-user use cases such as video broadcasting, conferencing, and media recording.
Jul. 30, 2016 10:45 AM EDT Reads: 1,120